Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

524
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
524
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

570
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.

The New England journal of medicine·2026
Same author

Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System Involvement.

Blood advances·2026
Same author

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

Blood cancer journal·2026
Same author

Metabolic heterogeneity and niche rewiring in bone marrow plasma cells from patients with MGUS, solitary bone plasmacytoma and multiple myeloma.

Blood cancer journal·2026
Same author

Monoclonal gammopathy of clinical significance: a multisystem review.

Blood cancer journal·2026
Same author

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination Survey.

Blood cancer journal·2026

Related Experiment Video

Updated: Oct 18, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K

Extramedullary disease in multiple myeloma.

Radhika Bansal1, Sagar Rakshit1, Shaji Kumar2

  • 1Division of Hematology, Mayo Clinic, Rochester, MN, USA, 55905.

Blood Cancer Journal
|September 30, 2021
PubMed
Summary

Extramedullary multiple myeloma (EMD) is a challenging condition with poorly understood mechanisms and poor outcomes. Despite aggressive treatments, survival remains limited, highlighting the need for new therapeutic strategies.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.2K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K

Related Experiment Videos

Last Updated: Oct 18, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.2K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K

Area of Science:

  • Hematology
  • Oncology
  • Clinical Medicine

Background:

  • Extramedullary multiple myeloma (EMD) involves plasma cell growth outside the bone marrow.
  • EMD presents significant therapeutic and biological challenges.
  • Pathogenesis is not fully understood and often linked to high-risk cytogenetics, indicating a poor prognosis.

Purpose of the Study:

  • To review the current understanding and challenges of extramedullary multiple myeloma (EMD).
  • To discuss the rising incidence and lack of standard treatment approaches for EMD in the era of novel agents.
  • To emphasize the need for further research and prospective trials for effective EMD treatment.

Main Methods:

  • Literature review of extramedullary multiple myeloma (EMD).
  • Analysis of current therapeutic strategies and outcomes.
  • Discussion of pathogenetic mechanisms and prognostic factors.

Main Results:

  • EMD incidence is rising, potentially due to increased overall survival (OS) with novel agents.
  • Aggressive chemotherapy offers some benefit, but OS and prognosis remain poor.
  • Radiotherapy (RT) is primarily used for palliative care in EMD.

Conclusions:

  • Extramedullary multiple myeloma (EMD) requires novel treatment strategies.
  • Further large-scale prospective trials are essential for developing effective EMD treatment approaches.
  • Understanding EMD pathogenesis is crucial for improving patient outcomes.